Abstract
摘要
相似文献
1
Boutiques reborn in 2003.
Nat Biotechnol. 2004 Mar;22(3):353-4.
2
Mixed results in Q1.
Nat Biotechnol. 2005 May;23(5):518. doi: 10.1038/nbt0505-518.
3
The rise of European venture capital for biotechnology.
Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.
4
Japanese firms broaden investment focus to early biotech.
Nat Biotechnol. 2004 Aug;22(8):931-2. doi: 10.1038/nbt0804-931.
5
Biotech IPOs--flop or pop?
Nat Biotechnol. 2004 Aug;22(8):949. doi: 10.1038/nbt0804-949.
6
Looking at US versus European exit opportunities.
Nat Biotechnol. 2005 Oct;23(10):1203.
7
Mind the (biomedical funding) gap.
Nat Biotechnol. 2005 Oct;23(10):1217-8. doi: 10.1038/nbt1005-1217.
8
VC funding hits high in Q1.
Nat Biotechnol. 2007 May;25(5):496. doi: 10.1038/nbt0507-496.
9
2006: a stellar year for financing.
Nat Biotechnol. 2007 Feb;25(2):156. doi: 10.1038/nbt0207-156.
10
Convincing a venture capitalist to invest in your idea.
Nat Biotechnol. 2003 Jul;21 Suppl:BE45-8.
Zotero 插件